Document 2420 DOCN M94A2420 TI Vertical transmission risk (VTR) of HIV-1 in Brazil: the impact of low loss to follow-up. DT 9412 AU Tess B; Rodrigues LC; Duarte G; Mussi-Pinhata MM; Cervi MC; Newell ML; Instituto de Saude, SP, Brazil. SO Int Conf AIDS. 1994 Aug 7-12;10(1):308 (abstract no. PC0160). Unique Identifier : AIDSLINE ICA10/94370155 AB OBJECTIVES: 1. To estimate the VTR of HIV-1 in Ribeirao Preto, Brazil. 2. To investigate the impact of low loss to follow up on the VTR of HIV-1. METHODS: An on-going retrospective (1988 to 1992) cohort study identified 112 HIV-positive mothers tested antenatally or at delivery at the University Hospital in Ribeirao Preto, Brazil. Children older than 18 months were assessed for HIV-infection through a serologic test (ELISA). Infant deaths were classified as indeterminate (children with unknown HIV infection status), HIV-related and non-HIV-related. A previous estimate of the VTR was 29.5% (95% CI 20 to 39) and it was based on a partially overlapping cohort but without intensive follow up. RESULTS: Of 112, intensive searching resulted in contacting 97 (86.6%) mother-child pairs; 2 study subjects refused to be tested and 6 children were classified as indeterminate when they died. Seventy one children were seronegative, 18 seropositive (7 of them died of AIDS). The VTR in this cohort was 20.2% (95% CI 11.8 to 28.5). Of 23 children who had been previously lost to follow up before 18 months of age and who were found through the intensive searching, 22 were seronegative for HIV-1. CONCLUSIONS: The VTR of HIV-1 in Ribeirao Preto (20.2%) was closer to the risks estimated in Europe and the USA than to the risks estimated in Africa. The large majority of children who lost contact with the health services and who were found through an intensive searching were HIV-1 seronegative. Less comprehensive follow up would have led to a much higher estimate of the VTR of HIV-1 in this cohort. DE Brazil Cohort Studies Female Human HIV Infections/*TRANSMISSION *HIV-1 Infant, Newborn Pregnancy *Pregnancy Complications, Infectious Retrospective Studies Risk Factors MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).